Literature DB >> 7585035

Multiple sclerosis: TNF revisited, with promise.

C S Raine1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7585035     DOI: 10.1038/nm0395-211

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  17 in total

1.  Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie.

Authors:  N A Mabbott; A Williams; C F Farquhar; M Pasparakis; G Kollias; M E Bruce
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

Review 2.  Exercise and brain health--implications for multiple sclerosis: Part II--immune factors and stress hormones.

Authors:  Lesley J White; Vanessa Castellano
Journal:  Sports Med       Date:  2008       Impact factor: 11.136

3.  Role of cytokine p40 family in multiple sclerosis.

Authors:  S Brahmachari; K Pahan
Journal:  Minerva Med       Date:  2008-04       Impact factor: 4.806

4.  Patterns of disease activity in multiple sclerosis patients: a study with quantitative gadolinium-enhanced brain MRI and cytokine measurement in different clinical subgroups.

Authors:  M Rovaris; D Barnes; N Woodrofe; G H du Boulay; J W Thorpe; A J Thompson; W I McDonald; D H Miller
Journal:  J Neurol       Date:  1996-07       Impact factor: 4.849

5.  Extracellular signal-regulated kinase and p38 subgroups of mitogen-activated protein kinases regulate inducible nitric oxide synthase and tumor necrosis factor-alpha gene expression in endotoxin-stimulated primary glial cultures.

Authors:  N R Bhat; P Zhang; J C Lee; E L Hogan
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

6.  Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine.

Authors:  K Norga; L Paemen; S Masure; C Dillen; H Heremans; A Billiau; H Carton; L Cuzner; T Olsson; J Van Damme
Journal:  Inflamm Res       Date:  1995-12       Impact factor: 4.575

7.  Late-onset chronic inflammatory encephalopathy in immune-competent and severe combined immune-deficient (SCID) mice with astrocyte-targeted expression of tumor necrosis factor.

Authors:  A K Stalder; M J Carson; A Pagenstecher; V C Asensio; C Kincaid; M Benedict; H C Powell; E Masliah; I L Campbell
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

8.  Oligodendrocyte apoptosis and primary demyelination induced by local TNF/p55TNF receptor signaling in the central nervous system of transgenic mice: models for multiple sclerosis with primary oligodendrogliopathy.

Authors:  K Akassoglou; J Bauer; G Kassiotis; M Pasparakis; H Lassmann; G Kollias; L Probert
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

9.  Differential expression, shedding, cytokine regulation and function of TNFR1 and TNFR2 in human fetal astrocytes.

Authors:  Sun Ju Choi; Kyoung-Ho Lee; Hyun Sook Park; Soo-Ki Kim; Choon-Myung Koh; Joo Young Park
Journal:  Yonsei Med J       Date:  2005-12-31       Impact factor: 2.759

10.  Induction of tumor necrosis factor-alpha (TNF-alpha) by interleukin-12 p40 monomer and homodimer in microglia and macrophages.

Authors:  Malabendu Jana; Subhajit Dasgupta; Ramendra N Saha; Xiaojuan Liu; Kalipada Pahan
Journal:  J Neurochem       Date:  2003-07       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.